S-MOXY 400 Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
S-MOXY 400
Moxifloxacin 400mg
S-MOXY 400 (Moxifloxacin 400mg) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in S-MOXY 400 deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C in a dry place. Protect from moisture and direct sunlight.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
S-MOXY 400 features Moxifloxacin 400mg prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Prescribed in our outpatient depart for S-MOXY 400
S-MOXY 400 has been prescribed in our outpatient department for over eight months, providing dependable relief from acute discomfort without noticeable lethargy. Bottles and blister strips feature secure tamper-resistant seals that chemists and patients appreciate. Patients frequently remark on the rapid symptomatic comfort and ease of taking this formulation.
Questions Regarding S-MOXY 400
What is the therapeutic indication and composition of S-MOXY 400?
S-MOXY 400 contains Moxifloxacin 400mg indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for S-MOXY 400?
S-MOXY 400 is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for S-MOXY 400?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for S-MOXY 400 along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
S-MOXY 400 is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Tablet
View all Tablet →
DAIBET-G2 V
Glimepiride 2mg + Metformin Hydrochloride 500mg + Voglibose 0.2mg Bilayered
